Elevance Health Reports Strong Q1 Earnings and Raises Full-Year Guidance

Elevance Health (ELV) reported Q1 adjusted EPS of $12.58, exceeding expectations and raising full-year 2026 guidance to at least $26.75. However, the increase was partially attributed to non-recurring investment income, and the company faces potential regulatory challenges with a $935 million accrual related to CMS risk-adjustment data.

By MarketBeat Fri, April 24, 2026 at 5:06 AM GMT+3 10 min read · Yahoo Finance · April 24, 2026, 02:06 UTC

Tickers: $ELV

Topics: CMS Risk-Adjustment Earnings Guidance Investment Income Stock Buybacks

Read the full article at Yahoo Finance

More World news

Teekay Tankers Shares Decline Despite Q3 Earnings Beat and New Vessel Orders Seeking Alpha · November 12, 2026, 18:27 UTC
U.S. 30-Year Treasury Auction Yields Rise as Demand Weakens Seeking Alpha · November 12, 2026, 18:30 UTC
Nvidia Names Colette Kress Interim CEO Following Jensen Huang's Resignation Motley Fool · November 12, 2026, 18:26 UTC
Bit Digital Reports Q3 2026 Net Income of $28.5 Million Amid Revenue Decline Motley Fool · November 12, 2026, 18:26 UTC
EZCORP Reports Strong Q4 2026 Results with Significant EBITDA and Revenue Growth Motley Fool · November 12, 2026, 18:16 UTC
Sabre Corp Shares Decline Following Travelport Denial of Merger Speculation Seeking Alpha · November 12, 2026, 18:21 UTC
Lufax Reports Third Quarter 2026 Net Loss Amid Rising Credit Impairment Costs Motley Fool · November 12, 2026, 18:15 UTC
Avantor Reports Return to Organic Revenue Growth in Third Quarter 2026 Motley Fool · November 12, 2026, 18:15 UTC
MGP Ingredients Rebrands to Sempreon and Announces Strategic Shift Toward Ready-to-Drink Products Motley Fool · November 12, 2026, 18:15 UTC
ICON Reports Q3 2026 Revenue of $2 Billion and Accelerating Book-to-Bill Ratio Motley Fool · November 12, 2026, 18:15 UTC